Mates Sharon Insider Trades

Insider Trading History

Track insider trading activity for Mates Sharon. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Benitec Biopharma
Benitec Biopharma BNTC
Director
Holding Value $348k 31,500 shares
Last Trade
Jan 22, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$404k 31,500 shares
$12.83
$11.05
Benitec Biopharma
Benitec Biopharma BNTC
Director
Holding Value $38.7k 3,500 shares
Last Trade
Dec 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$42.8k 3,500 shares
$12.23
$11.05
Benitec Biopharma
Benitec Biopharma BNTC
Director
Holding Value $315k 28,517 shares
Last Trade
Nov 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$450k 28,517 shares
$15.78
$11.05
Intra-Cellular Therapies
Intra-Cellular Therapies ITCI
Chairman And CEO
Holding Value $5.37M 40,712 shares
Last Trade
Apr 02, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$9.98M 75,682 shares
$131.87
$131.87
Intra-Cellular Therapies
Intra-Cellular Therapies ITCI
Chairman And CEO
Holding Value $0 0 shares
Last Trade
Apr 02, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$116M 876,581 shares
$131.87
$131.87
Intra-Cellular Therapies
Intra-Cellular Therapies ITCI
Chairman And CEO
Holding Value $25.1M 190,000 shares
Last Trade
Mar 26, 2025 Purchase (Gift)Shares transferred as a gift rather than bought or sold for cash.
$25M 190,000 shares
$131.69
$131.87
Intra-Cellular Therapies
Intra-Cellular Therapies ITCI
Chairman And CEO
Holding Value $125M 945,235 shares
Last Trade
Mar 26, 2025 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
$25M 190,000 shares
$131.69
$131.87
Intra-Cellular Therapies
Intra-Cellular Therapies ITCI
Chairman And CEO
Holding Value $0 0 shares
Last Trade
Mar 10, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.7M 20,566 shares
$131.25
$131.87
Intra-Cellular Therapies
Intra-Cellular Therapies ITCI
Chairman And CEO
Holding Value $150M 1,135,235 shares
Last Trade
Mar 10, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.33M 10,129 shares
$131.24
$131.87
Intra-Cellular Therapies
Intra-Cellular Therapies ITCI
Chairman And CEO
Holding Value $151M 1,145,364 shares
Last Trade
Mar 10, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.7M 20,566 shares
$131.25
$131.87
Intra-Cellular Therapies
Intra-Cellular Therapies ITCI
Chairman And CEO
Holding Value $151M 1,144,646 shares
Last Trade
Mar 06, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$5.34M 40,712 shares
$131.25
$131.87
Intra-Cellular Therapies
Intra-Cellular Therapies ITCI
Chairman And CEO
Holding Value $148M 1,124,798 shares
Last Trade
Mar 06, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$2.6M 19,848 shares
$131.19
$131.87
Intra-Cellular Therapies
Intra-Cellular Therapies ITCI
Chairman And CEO
Holding Value $5.37M 40,713 shares
Last Trade
Mar 06, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$5.34M 40,712 shares
$131.25
$131.87
Intra-Cellular Therapies
Intra-Cellular Therapies ITCI
Chairman And CEO
Holding Value $146M 1,103,934 shares
Last Trade
Mar 01, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$2.18M 16,978 shares
$128.20
$131.87
Intra-Cellular Therapies
Intra-Cellular Therapies ITCI
Chairman And CEO
Holding Value $9.22M 69,940 shares
Last Trade
Mar 01, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$4.48M 34,969 shares
$128.20
$131.87
Intra-Cellular Therapies
Intra-Cellular Therapies ITCI
Chairman And CEO
Holding Value $148M 1,120,912 shares
Last Trade
Mar 01, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$4.48M 34,969 shares
$128.20
$131.87
Intra-Cellular Therapies
Intra-Cellular Therapies ITCI
Chairman And CEO
Holding Value $16M 121,212 shares
Last Trade
Feb 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$15.4M 121,212 shares
$127.19
$131.87
Intra-Cellular Therapies
Intra-Cellular Therapies ITCI
Chairman And CEO
Holding Value $145M 1,101,176 shares
Last Trade
Jan 31, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.92M 30,847 shares
$127.08
$131.87
Intra-Cellular Therapies
Intra-Cellular Therapies ITCI
Chairman And CEO
Holding Value $143M 1,085,943 shares
Last Trade
Jan 31, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.93M 15,233 shares
$127.00
$131.87
Intra-Cellular Therapies
Intra-Cellular Therapies ITCI
Chairman And CEO
Holding Value $141M 1,071,863 shares
Last Trade
Dec 05, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$4.35M 51,697 shares
$84.08
$131.87

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up